Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our highly motivated Operations Team in Heidelberg, Germany, we are looking for a full-time
Reference No. OP2216
You will be involved in front-line and challenging research and development projects on novel technologies in the fields of therapeutic antibodies and cell therapy that enables the development and characterization of our product candidates.
For any queries, please contact Susanne Hering (Tel: +49 6221 6743 675, e-mail: firstname.lastname@example.org).
We are looking forward to receive your application (incl. motivation letter and salary expectations).